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The stringent response is a highly conserved physiological response mounted by 
bacteria under stress (Ojha and Chatterji, 2001; Magnusson et al., 2005; Srivatsan and 
Wang, 2007; Potrykus and Cashel, 2008). Until recently, the only known players in this 
pathway were the (p)ppGpp synthesizing and hydrolyzing long RSH enzymes 
(Mittenhuber, 2001; Atkinson et al., 2011) - RelA and SpoT in Gram negative bacteria 
and the bifunctional Rel in Gram positive bacteria including mycobacteria. The existence 
of Short Alarmone Synthetases (SAS) (Lemos et al., 2007, Nanamiya et al., 2008; Das et 
al., 2009; Atkinson et al., 2011) and Short Alarmone Hydrolases (SAH) (Sun et al., 2010, 
Atkinson et al., 2011), small proteins possessing a single functional (p)ppGpp synthetase 
or hydrolase domain respectively, is a recent discovery that has modified this paradigm. 
Around the same time that the presence of the SAS proteins was reported, we chanced 
upon such small (p)ppGpp synthetases in the genus Mycobacterium. The stringent 
response in the soil saprophyte Mycobacterium smegmatis was first reported by Ojha and 
co-workers (Ojha et al., 2000), and the bifunctional RSH, RelMsm, responsible for 
mounting the stringent response in this bacterium, has been characterized in detail (Jain et 
al., 2006 and 2007). RelMsm was the only known RSH enzyme present in M. smegmatis, 
and consequently, a strain of M. smegmatis deleted for the relMsm gene (ΔrelMsm) (Mathew 
et al., 2004), was expected to show a null phenotype for (p)ppGpp production. In this 
body of work, we report the surprising observation that the M. smegmatis ΔrelMsm strain is 
capable of synthesizing (p)ppGpp in vivo. This unexpected turn of events led us to the 
discovery of a second (p)ppGpp synthetase in this bacterium. The novel protein was 
found to possess two functional domains – an RNase HII domain at the amino-terminus, 
and a (p)ppGpp synthetase or RSD domain at the carboxy-terminus. We have therefore 
named this protein ‘MS_RHII-RSD’, indicating the two activities present and identifying 
the organism from which it is isolated. Orthologs of this novel SAS protein occur in other 
species of mycobacteria, both pathogenic and non-pathogenic. In this study, we report the 
cloning, purification and in-depth functional characterization of MS_RHII-RSD, and 
speculate on its in vivo role in M. smegmatis. 
 
Chapter 1 reviews the available literature in the field of stringent response 
research and lays the background to this study. A historical perspective is provided, 
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starting with the discovery of the stringent response in bacteria in the early 1960s, 
highlighting the development in this area till date. The roles played by the long and short 
RSH enzymes, ‘Magic Spot’ (p)ppGpp, the RNA polymerase enzyme complex, and a few 
other RNA and proteins are described, briefly outlining the inferences drawn from recent 
global gene expression and proteomics studies. The chapter concludes with a description 
of the motivation behind, and the scope of the present study. 
 
Chapter 2 discusses the in vivo and in silico identification of MS_RHII-RSD in 
M. smegmatis. Experiments performed for the genotypic and phenotypic revalidation of 
M. smegmatis ΔrelMsm strain are described.  Detailed bioinformatics analyses are provided 
for the in silico characterization of MS_RHII-RSD in terms of its domain architecture, in 
vivo localization, and protein structure prediction. A comprehensive list of the 
mycobacterial orthologs of MS_RHII-RSD from a few representative species of 
infectious and non-infectious mycobacteria is included.  
 
Chapter 3 summarizes the materials and methods used in the cloning, 
purification, and the biophysical and biochemical characterization of full length 
MS_RHII-RSD and its two domain variants – RHII and RSD, respectively. A detailed 
description of the purification protocols highlighting the specific modifications and 
changes made is given. Peptide mass fingerprinting to confirm protein identity, as well as 
preliminary mass spectrometric, chromatographic, and circular dichroism-based 
characterization of the proteins under study is also provided. 
 
Chapter 4 deals in detail with the in vivo and in vitro functional characterization 
of the RNase HII and (p)ppGpp synthesis activities of full length MS_RHII-RSD and its 
two domain variants - RHII and RSD, respectively. The RNase HII activity is 
characterized in vivo on the basis of a complementation assay in an E. coli strain deleted 
for the RNase H genes; while in vitro characterization is done by performing a FRET-
based assay to monitor the degradation of a RNA·DNA hybrid substrate in vitro. The 
(p)ppGpp synthesis activity is characterized in terms of the substrate specificity, 
magnesium ion utilization, and a detailed analysis of the kinetic parameters involved. A 
comparison of the (p)ppGpp synthesis activity of MS_RHII-RSD vis-à-vis that of the 
classical RSH protein, RelMsm, is also provided. Inferences drawn from (p)ppGpp 
hydrolysis assays and the in vivo expression profile of MS_RHII-RSD in M. smegmatis 
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wild type and ΔrelMsm strains are discussed. Based on the results of these functional 
assays, a model is proposed suggesting the probable in vivo role played by MS_RHII-
RSD in M. smegmatis. 
 
Chapter 5 describes the attempts at generating MS_RHII-RSD overexpression 
and knockout strains in M. smegmatis, using pJAM2-based mycobacterial expression 
system, and mycobacteriophage-based specialized transduction strategy, respectively. The 
detailed methodology and the principle behind the techniques used are explained. The 
results obtained so far, and the future work and strain characterization to be carried out in 
this respect are discussed. 
 
Chapter 6 takes a slightly different route and summarizes the work carried out in 
characterizing the glycopeptidolipids (GPLs) from M. smegmatis biofilm cultures. A 
general introduction about the mycobacterial cell wall components, with special emphasis 
on GPLs, is provided. The detailed protocols for chemical composition and 
chromatographic analyses are mentioned, and the future scope of this work is discussed. 
 
Appendix-1 briefly revisits the preliminary studies performed to determine the 
pppGpp binding site on M. smegmatis RNA polymerase using a mass spectrometry-based 
approach. Appendices-2, 3, 4 and 5 give a comprehensive list of the bacterial strains; 
PCR primers; antibiotics, buffers and media used; and the plasmid and phasmid maps, 
respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
